Argos Therapeutics Becomes Oversold (ARGS)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.

In trading on Wednesday, shares of Argos Therapeutics Inc. ( ARGS) entered into oversold territory, hitting an RSI reading of 29.6, after changing hands as low as $6.95 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 51.9. A bullish investor could look at ARGS's 29.6 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of ARGS shares:

START SLIDESHOW:
Find out what 9 other oversold stocks you need to know about »

Argos Therapeutics Inc. 1 Year Performance Chart

Looking at the chart above, ARGS's low point in its 52 week range is $5.61 per share, with $10.80 as the 52 week high point — that compares with a last trade of $7.09.

If you liked this article you might like

S&P 500 Trades Lower as Fed Signals Move on Rates 'Fairly Soon'

S&P 500 Trades Lower as Fed Signals Move on Rates 'Fairly Soon'

Dow Turns Positive in Wishy-Washy Trading Ahead of Fed Minutes

Dow Turns Positive in Wishy-Washy Trading Ahead of Fed Minutes

Argos Therapeutics Tanks on Committee Suggestion to Stop Carcinoma Drug Study

Argos Therapeutics Tanks on Committee Suggestion to Stop Carcinoma Drug Study

Stock Futures Waver as Wall Street Awaits Clarity From the Fed

Stock Futures Waver as Wall Street Awaits Clarity From the Fed

Argos Plummets 72%, Leads Biotech Movers

Argos Plummets 72%, Leads Biotech Movers